Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial. KAIMRC Ongoing PEGINTERFERON ALFA-2A/ RIBAVIRIN/ R0209963 3 RC14-055-R King Abdulaziz Medical City NG (Riyadh)
Efficacy and Safety of Intensive Insulin Therapy With Insulin Glulisine in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs Sanofi Ongoing Lantus® / Apidra® 4 LANTU_R_05048 National Diabetes Centre (Riyadh)
An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia Sanofi Ongoing 2-combination hypoglycaemics 4 DIREG_L_05386 Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen Sanofi Ongoing N/A 4 DRIEG_C_05756 King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia Sanofi Ongoing N/A 4 IRBEH_L_05674 King Khalid University Hospital (Riyadh)
Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI) Sanofi Ongoing N/A 4 DIREG_L_05229 Dr. Soliman Fakeeh Hospital (Jeddah)
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen. Sanofi Ongoing Lantus® + Apidra® 4 LANTU_R_05033 King Khalid University Hospital (Riyadh)
Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice Sanofi Ongoing Lantus®/Apidra® 4 LANTUR06314 Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women Sanofi Ongoing LACTOSERUM LACTIC ACID 4 LACACL06308 Dr. Erfan & Bagedo General Hospital (Jeddah)
multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 & 5D Sanofi Ongoing N/A 4 OBS13593 Saudi center for organ transplantation (Riyadh), King Fahad Hospital (Jeddah)
View 591 - 600 From 723